Xilio Therapeutics, Inc.XLONASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR-1.3%
5Y CAGR+9.5%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-1.3%/yr
Annual compound
5Y CAGR
+9.5%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$85.75M+28.1%
2024$66.93M-15.4%
2023$79.13M-11.2%
2022$89.15M+18.8%
2021$75.04M+37.5%
2020$54.56M+186.8%
2019$19.03M-